Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Facilitating Resolution of Life-Threatening Acute Graft-Versus-Host Disease By Supplementation of Human Chorionic Gonadotropin and Epidermal Growth Factor (Pregnyl): A Phase I Study

Blood (2018) 132 (Supplement 1): 71.

https://doi.org/10.1182/blood-2018-99-113564

Published: 2018

Journal Articles

Heme Potently Stimulates Tissue Factor Expression By Peripheral Blood Monocytes: A Novel Mechanism For Thrombosis In Intravascular Hemolytic Diseases

Teena Rehani, Ph.D., Kristin Mathson, B.S., John D Belcher, Ph.D., Gregory M Vercellotti, Arne Slungaard, MD

Blood (2013) 122 (21): 2215.

https://doi.org/10.1182/blood.V122.21.2215.2215

Published: 2013

Journal Articles

Thiocyanate Blocks Peroxidase-Dependent Extracellular Trap (ET) Formation By PMN and Eosinophils: Heme Is a Potent New Agonist For The ET Pathway

Kristin Mathson, B.S., Rehani Teena, Ph.D., John D Belcher, Ph.D., Gregory M Vercellotti, Arne Slungaard, MD

Blood (2013) 122 (21): 323.

https://doi.org/10.1182/blood.V122.21.323.323

Published: 2013

Journal Articles

Alternative Donor Hematopoietic Cell Transplantation for Patients with Fanconi Anemia.

Margaret L. MacMillan, MD, Bruce R. Blazar, MD, Todd E. Defor, MS, Kathryn E. Dusenbery, MD, Arne Slungaard, MD, Michael R. Verneris, MD, Jo-Anne H. Young, MD, Heather Zierhut, PhD, Daniel J. Weisdorf, MD, John E. Wagner, MD

Blood (2012) 120 (21): 3081.

https://doi.org/10.1182/blood.V120.21.3081.3081

Published: 2012

Journal Articles

The Major Phagocyte Peroxidase Product HOSCN Stimulates PMN and Eosinophil Adhesion to Endothelium by p38 MAPK-Dependent Enhancement of CD11b/18-ICAM-1 Binding,

Adria Jonas, M.S., Teena Rehani, Ph.D., Arne Slungaard, MD

Blood (2011) 118 (21): 3205.

https://doi.org/10.1182/blood.V118.21.3205.3205

Published: 2011

Journal Articles

The Major Phagocyte Peroxidase-Derived Oxidant HOSCN Stimulates Gene-Specific p38 MAPK- Dependent, NF-κb-Mediated Activation of Tissue Factor, VCAM-1 and ICAM-1 Expression In Endothelium.

Teena Rehani, Ph.D., Adria Jonas, M.S., Arne Slungaard, MD

Blood (2010) 116 (21): 1481.

https://doi.org/10.1182/blood.V116.21.1481.1481

Published: 2010

Journal Articles

The HDAC Inhibitors Trichostatin A (TSA) and Suberoylanilide Hydroxamic Acid (SAHA) Exhibit Multiple Modalities of Benefit for the Vascular Pathology of Sickle Disease.

Robert P Hebbel, MD, Gregory M. Vercellotti, MD, Betty Pace, MD, Anna Solovey, M.D., Rahn Kollander, Chine Abanonu, Julia Nguyen, BS, Julie V. Vineyard, BS, John D Belcher, Ph.D., Fuad Abdulla, Shade Osifuye, John W. Eaton, PhD, Robert Kelm, MD, Arne Slungaard, MD

Blood (2009) 114 (22): 2586.

https://doi.org/10.1182/blood.V114.22.2586.2586

Published: 2009

Journal Articles

Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia: Similar Efficacy of Non-Myeloablative and Myeloablative Conditioning; Long-Term Evaluation From the University of Minnesota.

Brian McClune, DO, Linda J. Burns, MD, Todd E. DeFor, MS, Arne Slungaard, MD, Veronika Bachanova, Claudio Brunstein, MD, PhD, Daniel J. Weisdorf

Blood (2009) 114 (22): 3385.

https://doi.org/10.1182/blood.V114.22.3385.3385

Published: 2009

Journal Articles

Gene-Specific Effects of the Histone Deacetylase Inhibitor TSA on Activation of a Pro-Inflammatory Endothelial Cell Phenotype by the Major Phagocyte Peroxidase-Derived Oxidant HOSCN.

Teena Pasrija, Ph.D., Shawn A Mahmud, Ph.D., John D Belcher, Ph.D., Gregory M. Vercellotti, MD, Arne Slungaard, MD

Blood (2008) 112 (11): 1274.

https://doi.org/10.1182/blood.V112.11.1274.1274

Published: 2008

Journal Articles

Lymphodepletion Followed by Donor Lymphocyte Infusions (DLI) Causes Significantly More Acute Graft Versus Host Disease Than DLI Alone.

Jeffrey S. Miller, MD, Daniel J. Weisdorf, MD, Linda J. Burns, MD, Arne Slungaard, MD, John E. Wagner, MD, Michael R. Verneris, MD, Sarah Cooley, MD, Rosanna Wangen, Susan K. Fautsch, Roby Nicklow, Todd DeFor, Bruce R. Blazar

Blood (2006) 108 (11): 260.

https://doi.org/10.1182/blood.V108.11.260.260

Published: 2006

Journal Articles

Release of High Levels of Platelet Factor 4 (PF4) from Platelets Improves Survival after a Lethal Lipopolysaccharide (LPS) Challenge.

M. Anna Kowalska, PhD, Michele P. Lambert, MD, Lubica Rauova, MD, PhD, William J. Smith, BS, Shawn A. Mahmud, BS, Mortimer Poncz, MD, Arne Slungaard, MD

Blood (2006) 108 (11): 61.

https://doi.org/10.1182/blood.V108.11.61.61

Published: 2006

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in the Treatment of Acute Lymphocytic Leukemia (ALL) in 126 Adults: Impact of Donor Source on Leukemia Free Survival (LFS).

Priya Kumar, MD, Todd E. Defor, MS, Claudio Brunstein, MD, Juliet Barker, MBBS(Hons), John E. Wagner, MD, Daniel J. Weisdorf, MD, Jeffrey S. Miller, MD, Philip McGlave, MD, Arne Slungaard, MD, Mukta Arora, MD, Marcie Tomblyn, MD, Linda J. Burns, MD

Blood (2005) 106 (11): 2064.

https://doi.org/10.1182/blood.V106.11.2064.2064

Published: 2005

Journal Articles

Endogenous Platelet PF4 Promotes In Vivo Activated Protein C (APC) Generation and Survival after Lethal Lipopolysaccharide Challenge in Mice: A Potential Physiologic Role for PF4.

M. Anna Kowalska, PhD, Shawn A. Mahmud, BA, Mortimer Poncz, MD, Arne Slungaard, MD

Blood (2005) 106 (11): 27.

https://doi.org/10.1182/blood.V106.11.27.27

Published: 2005

Journal Articles

Intravascular Tissue Factor (TF) Is Predominantly Platelet-Associated during the Aplastic Phase of Hematopoietic Stem Cell Transplantation (HSCT).

Marketa Markova, MD, Arne Slungaard, MD, Omer Aras, MD, Jessica L. Hysjulien, BS, Janel Long, BS, Arun Shet, MD, Ronald R. Bach, PhD, Nigel S. Key, MD

Blood (2004) 104 (11): 1928.

https://doi.org/10.1182/blood.V104.11.1928.1928

Published: 2004

Journal Articles

Successful Remission of Poor Prognosis AML after Adoptive Transfer and In Vivo Expansion of Human Haploidentical NK Cells.

Jeffrey S. Miller, MD, Yvette Soignier, Angela Panosskaltsis-Mortari, PhD, David McKenna, MD, Chap Le, PhD, Todd E. Defor, PhD, Linda J. Burns, MD, Paul J. Orchard, MD, Bruce R. Blazar, MD, John E. Wagner, MD, Arne Slungaard, MD, Daniel J. Weisdorf, MD, Ian J. Okazaki, MD, Philip B. McGlave, MD

Blood (2004) 104 (11): 260.

https://doi.org/10.1182/blood.V104.11.260.260

Published: 2004

NARROW

Facilitating Resolution of Life-Threatening Acute Graft-Versus-Host Disease By Supplementation of Human Chorionic Gonadotropin and Epidermal Growth Factor (Pregnyl): A Phase I Study

Heme Potently Stimulates Tissue Factor Expression By Peripheral Blood Monocytes: A Novel Mechanism For Thrombosis In Intravascular Hemolytic Diseases

Thiocyanate Blocks Peroxidase-Dependent Extracellular Trap (ET) Formation By PMN and Eosinophils: Heme Is a Potent New Agonist For The ET Pathway

Alternative Donor Hematopoietic Cell Transplantation for Patients with Fanconi Anemia.

The Major Phagocyte Peroxidase Product HOSCN Stimulates PMN and Eosinophil Adhesion to Endothelium by p38 MAPK-Dependent Enhancement of CD11b/18-ICAM-1 Binding,

The Major Phagocyte Peroxidase-Derived Oxidant HOSCN Stimulates Gene-Specific p38 MAPK- Dependent, NF-κb-Mediated Activation of Tissue Factor, VCAM-1 and ICAM-1 Expression In Endothelium.

The HDAC Inhibitors Trichostatin A (TSA) and Suberoylanilide Hydroxamic Acid (SAHA) Exhibit Multiple Modalities of Benefit for the Vascular Pathology of Sickle Disease.

Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia: Similar Efficacy of Non-Myeloablative and Myeloablative Conditioning; Long-Term Evaluation From the University of Minnesota.

Gene-Specific Effects of the Histone Deacetylase Inhibitor TSA on Activation of a Pro-Inflammatory Endothelial Cell Phenotype by the Major Phagocyte Peroxidase-Derived Oxidant HOSCN.

Lymphodepletion Followed by Donor Lymphocyte Infusions (DLI) Causes Significantly More Acute Graft Versus Host Disease Than DLI Alone.

Release of High Levels of Platelet Factor 4 (PF4) from Platelets Improves Survival after a Lethal Lipopolysaccharide (LPS) Challenge.

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in the Treatment of Acute Lymphocytic Leukemia (ALL) in 126 Adults: Impact of Donor Source on Leukemia Free Survival (LFS).

Endogenous Platelet PF4 Promotes In Vivo Activated Protein C (APC) Generation and Survival after Lethal Lipopolysaccharide Challenge in Mice: A Potential Physiologic Role for PF4.

Intravascular Tissue Factor (TF) Is Predominantly Platelet-Associated during the Aplastic Phase of Hematopoietic Stem Cell Transplantation (HSCT).

Successful Remission of Poor Prognosis AML after Adoptive Transfer and In Vivo Expansion of Human Haploidentical NK Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only